|
rdf:type |
|
|
rdfs:label |
TYSABRI (Injection)
|
|
dailymed-instance:activeIng... |
|
|
dailymed-instance:genericDr... |
|
|
dailymed-instance:boxedWarn... |
WARNING: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the brain that usually leads to death or severe disability. Cases of PML have been reported in patients taking TYSABRI who were recently or concomitantly treated with immunomodulators or immunosuppressants, as well as in patients receiving TYSABRI as monotherapy [seeWarnings and Precautions (5.1)].
|
|
dailymed-instance:activeMoi... |
|
|
dailymed-instance:inactiveI... |
|
|
dailymed-instance:possibleD... |
diseasome-diseases:1173,
diseasome-diseases:1693,
diseasome-diseases:1694,
diseasome-diseases:181,
diseasome-diseases:2789,
diseasome-diseases:3004,
diseasome-diseases:3020,
diseasome-diseases:3044,
diseasome-diseases:3365,
diseasome-diseases:4136,
diseasome-diseases:602,
diseasome-diseases:698,
diseasome-diseases:701,
diseasome-diseases:710,
diseasome-diseases:833
|
|
dailymed-instance:genericMe... |
natalizumab
|
|
dailymed-instance:fullName |
TYSABRI (Injection)
|
|
dailymed-instance:represent... |
|
|
dailymed-instance:routeOfAd... |
|
|
dailymed-instance:name |
TYSABRI
|
